Tivity Health (NASDAQ:TVTY) Stock Price Passes Above 200 Day Moving Average of $19.41

Tivity Health, Inc. (NASDAQ:TVTY) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $19.41 and traded as high as $23.94. Tivity Health shares last traded at $23.30, with a volume of 325,570 shares traded.

Several research analysts have commented on the stock. Piper Sandler raised their target price on shares of Tivity Health from $16.00 to $27.00 in a report on Thursday, February 25th. Truist raised their target price on shares of Tivity Health from $18.00 to $22.00 in a report on Tuesday, January 5th. Credit Suisse Group raised their target price on shares of Tivity Health from $19.00 to $20.00 and gave the stock an “underperform” rating in a report on Thursday, March 4th. Barrington Research raised their target price on shares of Tivity Health from $28.00 to $32.00 and gave the stock an “outperform” rating in a report on Thursday, February 25th. Finally, Zacks Investment Research cut shares of Tivity Health from a “buy” rating to a “hold” rating in a report on Thursday, March 25th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $22.67.

The company has a debt-to-equity ratio of 435.23, a current ratio of 1.04 and a quick ratio of 0.88. The firm has a market capitalization of $1.13 billion, a price-to-earnings ratio of -2.11, a PEG ratio of 1.60 and a beta of 2.49. The firm’s fifty day moving average is $23.58 and its 200 day moving average is $19.46.

Tivity Health (NASDAQ:TVTY) last posted its earnings results on Wednesday, February 24th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.07. The firm had revenue of $100.62 million during the quarter, compared to analysts’ expectations of $218.55 million. Tivity Health had a negative net margin of 47.44% and a positive return on equity of 128.43%. Equities research analysts forecast that Tivity Health, Inc. will post 1.74 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently bought and sold shares of the business. US Bancorp DE lifted its stake in Tivity Health by 116.8% in the fourth quarter. US Bancorp DE now owns 5,367 shares of the company’s stock valued at $105,000 after acquiring an additional 2,892 shares during the last quarter. Aperio Group LLC acquired a new stake in Tivity Health in the third quarter valued at approximately $181,000. Bailard Inc. acquired a new stake in Tivity Health in the fourth quarter valued at approximately $197,000. ProShare Advisors LLC acquired a new stake in Tivity Health in the fourth quarter valued at approximately $202,000. Finally, OLD Mission Capital LLC acquired a new stake in Tivity Health in the third quarter valued at approximately $212,000. Hedge funds and other institutional investors own 91.57% of the company’s stock.

About Tivity Health (NASDAQ:TVTY)

Tivity Health, Inc provides fitness, nutrition, and social connection solutions in the United States. It operates through two segments, Healthcare and Nutrition. The Healthcare segment offers SilverSneakers senior fitness program to the members of Medicare advantage and Medicare supplement programs; Prime fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others.

Featured Article: What are the risks of holding treasury bonds?

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.